Dr Bridget Agboola is a medical doctor currently undertaking academic internal medicine training in the U.K. With a strong clinical interest in pharmacology, patient safety, and medical education, Dr Agboola has focused recent research on improving prescribing practices for patients with complex or high-risk conditions, including myasthenia gravis. During clinical training, Dr Agboola identified a knowledge gap in safe prescribing among early-career clinicians and has since undertaken educational research aimed at addressing this through curriculum development and targeted interventions. This work builds on a broader commitment to improving clinical outcomes through better integration of pharmacological knowledge into real-world medical practice. She has been actively involved in medical education initiatives at both undergraduate and postgraduate levels, contributing to the design and delivery of case-based teaching and clinical pharmacology workshops. Dr Agboola's long-term goal is to help shape medical education to better equip clinicians with the pharmacological understanding needed to minimise harm and improve patient care.